Delivery Order SPE2DR25D3012-SPE2DR26F4C9A
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 31, 2025, for the supply of Progesterone 100 mg capsules (100-count units) with a ceiling value of $2,357.53. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is scheduled for completion by November 3, 2025. The order will be fulfilled from AmerisourceBergen's corporate offices in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $24,894.40 delivery order to AmerisourceBergen Drug Corp on December 8, 2025, for the supply of Progesterone 100 mg capsules (100-count units). The contract represents a firm fixed-price delivery order with an ultimate completion date of December 9, 2025, and carries no set-aside designation, indicating it was competitively awarded. Performance will be executed from AmerisourceBergen's Conshohocken, Pennsylvania location, the company's corporate...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Progesterone 100 mg capsules (100-count units) with a ceiling value of $30,912.13. This firm fixed-price delivery order, which is expected to be completed by August 15, 2025, will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract was awarded through open competition with no set-aside designation, reflecting the...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $11,292.07 on August 27, 2025, for the supply of Progesterone 100 mg capsules (100-count units). This contract represents a non-competitive, firm fixed-price delivery order with performance completion scheduled for August 28, 2025, and will be executed from AmerisourceBergen's facility in Conshohocken, Pennsylvania. No set-aside designation was applied to this award. This delivery order falls under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 22, 2025, for the supply of Progesterone 100 mg capsules (100-count units) with a ceiling value of $1,163.95. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was made through competitive procurement. The order is set for ultimate completion on October 23, 2025, and will be fulfilled from AmerisourceBergen's corporate office in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Progesterone 100 mg capsules (100-count units) under a firm fixed-price contract with a ceiling value of $1,040.22. The delivery order, issued on December 5, 2025, with an ultimate completion date of December 8, 2025, represents a non-competitive, competitively awarded procurement supporting federal medical supply requirements. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform this...
- The Defense Logistics Agency awarded a $1,152.00 delivery order to AmerisourceBergen Drug Corp for Progesterone 100 mg capsules (100-count) on July 30, 2025, with a completion date of July 31, 2025. This is a firm fixed price, non-set-aside contract performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999.00...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Progesterone 100 mg capsules (100-count units) valued at $4,634.48. This firm fixed-price delivery order, with an ultimate completion date of August 26, 2025, represents a non-competitive award under the company's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion vehicle running through December 2026. The place of...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 28, 2025, for the supply of Progesterone 100 mg capsules (100-count units) with a ceiling value of $1,606.93. This is a firm fixed-price delivery order with no set-aside designation, issued competitively to the major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania. The order is scheduled for completion by August 29, 2025, and will be fulfilled from the vendor's Pennsylvania...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,544.34 to AmerisourceBergen Drug Corp for Progesterone 100 mg capsules (100-count units) on September 16, 2025, with an ultimate completion date of September 17, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is being performed in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. The delivery order is classified as a child contract, indicating...
- SPE2DR25D3012Indefinite Delivery Contract
- SPE2DR25D3012-SPE2DR26F4C9ADelivery Order
The Defense Logistics Agency awarded a $3,476.30 delivery order to AmerisourceBergen Drug Corp on December 4, 2025, for the supply of Progesterone 100 mg capsules (100-count units). This contract was competitively awarded with no set-aside designation and carries a firm fixed price structure with an ultimate completion date of December 5, 2025. The award will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (designated SPE2DX), valued at $999,999,999.00 and extending through December 2026. This prime contract vehicle enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company serves as a critical vendor for the Defense Health Agency and other federal healthcare systems, with a demonstrated portfolio encompassing specialty medications, generic and brand-name drugs, vaccines, and medical supplies across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.5k | 12/3/25 |